Opinion
Video
An Overview of Fusion-Guided Systems
Author(s):
A urologic oncologist discusses how MRI- or fusion-guided biopsies have helped overcome the limitations of traditional prostate biopsies.
Video Player is loading.
Video content above is prompted by the following questions:
- What is the difference between software and cognitive fusion? Why might you prefer one over the other? Are all systems the same?
- A recent study indicated that detection rates were similar. Have you found that to be true in clinical practice?
- What are key differences between rigid fusion and elastic fusion? Between organ-based tracking and probe tracking technologies?
Related Videos
Stephen J. Freedland, MD, on the benefits of mCRPC treatments translating to the real world
Preston Sprenkle, MD, highlights trial of TULSA vs radical prostatectomy
Expert discusses the relationship between RCTs and real-world efficacy of prostate cancer treatments
Study data point to gender disparities in oncology research citations
Matthew Galsky, MD, on patient selection for perioperative durvalumab/chemo in MIBC
Nitin Yerram, MD, highlights trial of 177Lu-PSMA-617 in localized prostate cancer
Neeraj Agarwal, MD, shares key takeaways from TALAPRO-2
Betty Wang, MD, recaps 3 key urologic cancer studies from EAU 2025
Neeraj Agarwal, MD, on the safety profile of talazoparib/enzalutamide in mCRPC
Matthew Galsky, MD, reacts to NIAGARA results, durvalumab approval for MIBC
Related Content
